Zevra Therapeutics, Inc.ZVRANASDAQ
Loading
EBITDA as a percentage of revenue
Latest
92.71%
↑ 209% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
-84.71%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 92.71% | +128.7% |
| 2024 | -323.56% | -104.1% |
| 2023 | -158.56% | +36.9% |
| 2022 | -251.22% | -812.4% |
| 2021 | -27.53% | +32.6% |
| 2020 | -40.87% | +70.4% |
| 2019 | -138.06% | - |
| 2018 | 0.00% | - |
| 2017 | 0.00% | - |
| 2016 | 0.00% | - |